PSMB5 and Miyoshi myopathy: Mutations in the PSMB5 gene that reduce the affinity for association with Bortezomib have been recognized in many MM patients and in in vitro settings over the years [44,47,48]; however, not all resistant phenotypes carry PSMB5 mutated alleles.